Guggenheim Initiates Coverage on Sagimet Biosciences with Buy Rating and $27 PT

martes, 3 de febrero de 2026, 11:46 am ET1 min de lectura
SGMT--

Guggenheim Initiates Coverage on Sagimet Biosciences with Buy Rating and $27 PT

Guggenheim Initiates Coverage on Sagimet Biosciences with Buy Rating and $27 PT

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios